Search Results

Displaying Results 1-2 of 2 "'SPAQ'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.

Aug 27, 2026, 07:02 ET Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion

artesunate for injection worldwide, saving more than 92 million patients with severe malaria. The "Seasonal Malaria Chemoprevention Program", centered on the SPAQ-CO® series of products, has benefited more than 330 million children in Africa.The "Rural Doctors Program", initiated by Fosun Foundation, continued

More news about: Fosun

May 27, 2026, 05:38 ET Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List

malaria patients worldwide, with more than 440 million doses supplied globally. The Seasonal Malaria Chemoprevention (SMC) program, centered on the SPAQ-CO product portfolio, had benefited more than 330 million children in Africa. In addition, the main structure of Phase I of the Côte d'Ivoire industrial

More news about: Fosun

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.